blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1585511

EP1585511 - ASTHMA AND ALLERGIC INFLAMMATION MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.11.2013
Database last updated on 03.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2013/04]
Former [2006/33]For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
Former [2005/42]For all designated states
TULARIK, INC.
1120 Veterans Boulevard South San Francisco
California 94080 / US
Inventor(s)01 / FU, Zice
788 Santa Maria Lane
Foster City, CA 94404 / US
02 / HUANG, Xi, Alan
3061 La Selva, C-207
San Mateo, CA 94403 / US
03 / LIU, Jiwen
721 Celestial Lane
Foster City, CA 94404 / US
04 / MEDINA, Julio, C.
1407 Cedar Street
San Carlos, CA 94070 / US
05 / SCHMITT, Michael, J.
2137 Larkin Street
San Francisco, CA 94109 / US
06 / TANG, Lucy, H.
42 Levant Street
San Francisco, CA 94114 / US
07 / WANG, Yingcai
1824 El Parque Court, Apt. C
San Mateo, CA 94403 / US
08 / XU, Qingge
2001 Trousdale Drive
Apt. 203
Burlingame, CA 94010 / US
 [2013/04]
Former [2007/08]01 / FU, Zice
788 Santa Maria Lane
Foster City, CA 94404 / US
02 / HUANG, Xi, Alan
3061 La Selva, C-207
San Mateo, CA 94403 / US
03 / LIU, Jiwen
721 Celestial Lane
Foster City, CA 94404 / US
04 / MEDINA, Julio, C.
1407 Cedar Street
San Carlos, CA 94070 / US
05 / SCHMITT, Michael, J.
2137 Larkin Street
San Francisco, CA 94109 / US
06 / TANG, Lucy, H.
42 Levant Street
San Francisco, CA 94114 / US
07 / WANG, Yingcai
1824 El Parque Court, Apt. C
San Mateo, CA 94403 / US
08 / XU, Qingge
2001 Trousdale Drive, Apt. 203
Burlingame, CA 94010 / US
Former [2005/42]01 / FU, Zice
1050 Carolan Avenue, Apt. 202
Burlingame, CA 94010 / US
02 / HUANG, Xi, Alan
3061 La Selva, C-207
San Mateo, CA 94403 / US
03 / LIU, Jiwen
721 Celestial Lane
Foster City, CA 94404 / US
04 / MEDINA, Julio, C.
1407 Cedar Street
San Carlos, CA 94070 / US
05 / SCHMITT, Michael, J.
2137 Larkin Street
San Francisco, CA 94109 / US
06 / TANG, Lucy, H.
42 Levant Street
San Francisco, CA 94114 / US
07 / WANG, Yingcai
1824 El Parque Court, Apt. C
San Mateo, CA 94403 / US
08 / XU, Qingge
2001 Trousdale Drive, Apt. 203
Burlingame, CA 94010 / US
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2013/04]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2012/02]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Former [2008/43]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München / DE
Former [2005/42]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte, Prinzregentenstrasse 11
80538 München / DE
Application number, filing date03814219.619.12.2003
[2005/42]
WO2003US40617
Priority number, dateUS20020435366P20.12.2002         Original published format: US 435366 P
[2005/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004058164
Date:15.07.2004
Language:EN
[2004/29]
Type: A2 Application without search report 
No.:EP1585511
Date:19.10.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 15.07.2004 takes the place of the publication of the European patent application.
[2005/42]
Type: B1 Patent specification 
No.:EP1585511
Date:23.01.2013
Language:EN
[2013/04]
Search report(s)International search report - published on:US26.08.2004
(Supplementary) European search report - dispatched on:EP30.07.2007
ClassificationIPC:A61K31/18, C07C205/37, C07C233/75, C07C271/28, C07C275/42, C07C311/08, C07C311/21, C07D209/22, C07D213/71, C07D215/36, C07D233/84, C07D243/12, C07D333/34, C07D257/04, C07D307/91, C07D295/192, C07C317/44, A61P29/00, A61P37/08, A61P11/06
[2012/33]
CPC:
C07C205/37 (EP,US); C07C311/21 (EP,KR,US); A61P1/04 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P9/10 (EP);
C07C205/56 (EP,US); C07C233/75 (EP,US); C07C271/28 (EP,US);
C07C275/42 (EP,US); C07C311/08 (EP,US); C07C311/29 (EP,US);
C07C317/44 (EP,US); C07D209/22 (EP,US); C07D209/26 (EP,US);
C07D213/71 (EP,US); C07D215/36 (EP,US); C07D233/84 (EP,US);
C07D243/12 (EP,US); C07D243/24 (EP,US); C07D257/04 (EP,US);
C07D295/192 (EP,US); C07D307/91 (EP,US); C07D333/34 (EP,US);
C07D333/62 (EP,US); C07C2601/04 (EP,US); C07C2601/08 (EP,US) (-)
Former IPC [2005/42]A61K31/18
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/42]
TitleGerman:MODULATOREN VON ASTHMA UND ALLERGISCHER ENTZÜNDUNG[2005/42]
English:ASTHMA AND ALLERGIC INFLAMMATION MODULATORS[2005/42]
French:MODULATEURS DE L'ASTHME ET DE L'INFLAMMATION ALLERGIQUE[2005/42]
Entry into regional phase18.07.2005National basic fee paid 
18.07.2005Search fee paid 
18.07.2005Designation fee(s) paid 
18.07.2005Examination fee paid 
Examination procedure16.07.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
18.07.2005Examination requested  [2005/42]
20.09.2005Amendment by applicant (claims and/or description)
04.05.2009Despatch of a communication from the examining division (Time limit: M06)
16.09.2009Reply to a communication from the examining division
01.10.2010Despatch of a communication from the examining division (Time limit: M06)
06.04.2011Reply to a communication from the examining division
14.11.2011Despatch of a communication from the examining division (Time limit: M06)
03.04.2012Reply to a communication from the examining division
27.07.2012Communication of intention to grant the patent
27.11.2012Fee for grant paid
27.11.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.05.2009
Opposition(s)24.10.2013No opposition filed within time limit [2014/01]
Fees paidRenewal fee
15.12.2005Renewal fee patent year 03
13.12.2006Renewal fee patent year 04
12.12.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
11.12.2009Renewal fee patent year 07
15.12.2010Renewal fee patent year 08
12.12.2011Renewal fee patent year 09
11.12.2012Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.12.2003
AT23.01.2013
BE23.01.2013
CY23.01.2013
CZ23.01.2013
DK23.01.2013
EE23.01.2013
FI23.01.2013
MC23.01.2013
NL23.01.2013
RO23.01.2013
SE23.01.2013
SI23.01.2013
SK23.01.2013
TR23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
[2015/34]
Former [2015/32]AT23.01.2013
BE23.01.2013
CY23.01.2013
CZ23.01.2013
DK23.01.2013
EE23.01.2013
FI23.01.2013
MC23.01.2013
NL23.01.2013
RO23.01.2013
SE23.01.2013
SI23.01.2013
SK23.01.2013
TR23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
Former [2014/33]AT23.01.2013
BE23.01.2013
CY23.01.2013
CZ23.01.2013
DK23.01.2013
EE23.01.2013
FI23.01.2013
MC23.01.2013
NL23.01.2013
RO23.01.2013
SE23.01.2013
SI23.01.2013
SK23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
Former [2013/49]AT23.01.2013
BE23.01.2013
CY23.01.2013
CZ23.01.2013
DK23.01.2013
EE23.01.2013
FI23.01.2013
NL23.01.2013
RO23.01.2013
SE23.01.2013
SI23.01.2013
SK23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
Former [2013/48]AT23.01.2013
BE23.01.2013
CY23.01.2013
DK23.01.2013
EE23.01.2013
FI23.01.2013
NL23.01.2013
SE23.01.2013
SI23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
Former [2013/40]AT23.01.2013
BE23.01.2013
CY23.01.2013
FI23.01.2013
NL23.01.2013
SE23.01.2013
SI23.01.2013
BG23.04.2013
GR24.04.2013
PT23.05.2013
Former [2013/37]AT23.01.2013
BE23.01.2013
CY23.01.2013
FI23.01.2013
NL23.01.2013
SE23.01.2013
SI23.01.2013
BG23.04.2013
GR24.04.2013
Former [2013/36]AT23.01.2013
BE23.01.2013
CY23.01.2013
SE23.01.2013
BG23.04.2013
Former [2013/35]BE23.01.2013
CY23.01.2013
SE23.01.2013
BG23.04.2013
Former [2013/34]SE23.01.2013
BG23.04.2013
Documents cited:Search[X]WO9533461  (SMITHKLINE BEECHAM CORP [US], et al) [X] 27 * the whole document *;
 [X]EP0947500  (ONO PHARMACEUTICAL CO [JP]) [X] 1,23* example 18(39); claims 1,15 *;
 [X]  - MUNNS, M. J. ET AL, "Contribution of Type II PLA2 to prostaglandin formation: a study using a Type II PLA2 specific inhibitor SB 203347", PROSTAGLANDINS & OTHER LIPID MEDIATORS, 57(5,6), 361-370 CODEN: POLMFL; ISSN: 1098-8823, (1999), XP004179325 [X] 27 * page 362, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0090-6980(99)00012-X
International searchWO03016254  [ ] (ONO PHARMACEUTICAL CO [JP], et al);
 [A]  - TANI ET AL, "Preparation of aryl or heterocyclyl-substituted benzoic acid andand alkanoic acid derivatives as antagonists of prostaglandin E2 (PEG2) receptors", CA, Database accession no. 2003:154382, XP002992801
Examination   - LIU JIWEN ET AL, "Discovery and optimization of CRTH2 and DP dual antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (200911), vol. 19, no. 22, ISSN 0960-894X, pages 6419 - 6423
by applicantWO9533461
 EP0947500
    - BERGE ET AL., J. PHARM. SCI., (1977), vol. 66, pages 1 - 19
    - The Practice of Medicinal Chemistry, ACADEMIC PRESS, (1996), page 203
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.